Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Aprea Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- 0 vs. Q4 2021
- Shares held
- 2.42M
- −1.19M (−33.0%) vs. Q4 2021
- Total value
- $4.50M
- −$5.86M (−56.6%) vs. Q4 2021
- New holders
- 9
- 8 more added
- Sold out
- 9
- 16 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 355,490 | $662.0K | 0.00% | −341,336−49.0% | Reduced |
| Kennedy Capital Management, Inc. | 334,796 | $623.0K | 0.01% | −1,934−0.6% | Reduced |
| Renaissance Technologies LLC | 297,900 | $554.0K | 0.00% | +15,977+5.7% | Added |
| Morgan Stanley | 246,944 | $459.0K | 0.00% | −79,266−24.3% | Reduced |
| BlackRock Inc. | 230,165 | $428.0K | 0.00% | −2,046−0.9% | Reduced |
| Geode Capital Management, LLC | 150,142 | $279.0K | 0.00% | −10.0% | Reduced |
| Susquehanna International Group, LLP | 111,369 | $208.0K | 0.00% | +45,580+69.3% | Added |
| Citadel Advisors LLC | 77,082 | $143.0K | 0.00% | −86,179−52.8% | Reduced |
| Bridgeway Capital Management, LLC | 60,000 | $112.0K | 0.00% | −15,000−20.0% | Reduced |
| Group One Trading, L.P. | 53,104 | $99.0K | 0.00% | −16,736−24.0% | Reduced |
| Crestline Management, LP | 49,451 | $92.0K | 0.01% | +49,451 | New |
| Susquehanna Fundamental Investments, LLC | 49,100 | $91.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 40,832 | $76.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 33,431 | $62.0K | 0.00% | +11,405+51.8% | Added |
| JPMorgan Chase & Co | 29,509 | $55.0K | 0.00% | −165,305−84.9% | Reduced |
| PDT Partners, LLC | 29,447 | $55.0K | 0.00% | −113,153−79.3% | Reduced |
| Northern Trust Corp | 29,205 | $54.0K | 0.00% | −5,747−16.4% | Reduced |
| Goldman Sachs Group Inc | 29,109 | $54.0K | 0.00% | +5,285+22.2% | Added |
| Cubist Systematic Strategies, LLC | 20,572 | $38.0K | 0.00% | +20,572 | New |
| Gyon Technologies Capital Management, LP | 20,570 | $38.0K | 0.03% | +20,570 | New |
| Verition Fund Management LLC | 20,101 | $37.0K | 0.00% | −27−0.1% | Reduced |
| Two Sigma Investments, LP | 18,610 | $35.0K | 0.00% | +18,610 | New |
| Bank of New York Mellon Corp | 16,703 | $31.0K | 0.00% | −140−0.8% | Reduced |
| Blackstone Group Inc. | 16,590 | $31.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 16,884 | $31.0K | 0.00% | +16,884 | New |
| Magnus Financial Group LLC | 14,856 | $28.0K | 0.00% | −19,125−56.3% | Reduced |
| Virtu Financial LLC | 13,835 | $26.0K | 0.00% | −28,120−67.0% | Reduced |
| Quantamental Technologies LLC | 12,752 | $24.0K | 0.01% | −1,000−7.3% | Reduced |
| Royal Bank of Canada | 11,700 | $22.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 10,000 | $19.0K | 0.00% | +10,000 | New |
| UBS Group AG | 5,260 | $10.0K | 0.00% | +5,185+6,913.3% | Added |
| Bank of America Corp | 4,183 | $8.00K | 0.00% | +4,043+2,887.9% | Added |
| Federated Hermes, Inc. | 3,554 | $7.00K | 0.00% | +49+1.4% | Added |
| Sugarloaf Wealth Management, LLC | 1,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,773 | $3.00K | 0.00% | +1,773 | New |
| Advisor Group Holdings, Inc. | 1,050 | $2.00K | 0.00% | 00.0% | Unchanged |
| Kistler-Tiffany Companies, LLC | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 500 | $1.00K | 0.00% | +500 | New |
| Wells Fargo & Company | 96 | $0 | 0.00% | +1+1.1% | Added |
| Quent Capital, LLC | 75 | $0 | 0.00% | +75 | New |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −433,859−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −27,285−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −21,202−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −17,326−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −15,173−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −14,880−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,395−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −183−100.0% | Sold out |
| NEXT Financial Group, Inc | – | – | – | – | Not filed |